SLC1A2 and Cognitive impairment: Taken together, it seems that CEF treatment associated with cognitive function improvement in animal models of different cognitive impairments is reported after extended treatment (14-60 days) and other mechanisms of action might be involved besides GLT-1 upregulation such as increase in the activity of the GS enzyme, increase in neurogenesis, and decrease in microglial activation.